<< Back to Chromatin Club Home Page

Cambridge Cancer Epigenetics Club
The Imperial - Cambridge Cancer Epigenetics Club (CCEC) is thrilled to bring to you inspiring talks that share cutting edge research from leading labs across the globe. Our platform is designed for educational purposes and to foster networking within the Cancer Epigenetics community.
CCEC hosts monthly seminars to delve into the latest developments in Cancer Epigenetics, stimulate collaborations, and provide networking opportunities.
Chairs: Shuchi Agrawal-Singh, Imperial College London; Brian Huntly, University of Cambridge
To register your interest or for more information, please visit the CCEC website: https://www.haem.cam.ac.uk/events/cancer-chromatin-and-epigenetics-club
OR contact Dr. Shuchi Agrawal Singh at [email protected]
Stay Connected: Stay tuned for updates on our next speaker and their topic! Follow us on Twitter for updates: @CancrEpigenetic
Join us in exploring the forefront of Cancer Epigenetics research and building valuable connections within our community. We look forward to seeing you at our next seminar!
Founders and Co-Organizers:
- Dr. Shuchi Agrawal Singh
- Professor Brian Huntly
Sponsored By: Active Motif
Upcoming Event Details
Date: June 1, 2026
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- Álvaro Rada-Iglesias, Ph.D. - Research Professor, Institute of Biomedicine and Biotechnology of Cantabria, University of Cantabria
Synergy Among Enhancers Involves an Increase in Transcriptionally Productive Enhancer-Promoter Contact
Past Event Details
Date: May 1, 2026
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- James Davies, DPhil, MRCP. - Professor of Genomics, Weatherall Institute of Medicine, University of Oxford
Defining Chromatin Architecture at Base Pair Resolution
Date: March 20, 2026
Time: 8:00 a.m. (PDT) / 3:00 p.m. (GMT)
Keynote Speakers:
- Iva Tchasovnikarova, Ph.D. - Group Leader, The Gurdon Institute, University of Cambridge
Fluorogenetic Interrogation of Epigenetic Repression
Date: February 6, 2026
Time: 7:00 a.m. (PST) / 3:00 p.m. (GMT)
Keynote Speakers:
- Daniel Tenen, M.D. - Professor at Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center
Methylation "Mesa" Define Functional Regulatory Elements for Targeted Gene Activation
Date: December 12, 2025
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- Ari Melnick, M.D., Ph.D. - Director at Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Epigenetic Basis and Therapy of Immune System Cancers
Date: October 24, 2025
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- Gregoire Stik, Ph.D. - Jr. Group Leader at Josep Carreras Leukaemia Research Institute, Spain
Mechanistic Insights into Chromatin Organization and Leukemia Driven by Biomolecular Condensation
Date: September 5, 2025
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- Christa Buecker, Ph.D. - Group Leader at Max Perutz Labs, Vienna, Austria
Building to Understand: Enhancer-Promoter Communication in the Context of Regulatory Landscapes
Date: June 6, 2025
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- Eirini Trompouki, Ph.D. - Group Leader at IRCAN - Institute for Research on Cancer and Aging, France
RNA Sensing in Aging and Regeneration
Date: May 16, 2025
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speakers:
- Marieke Oudelaar, Ph.D. - Lise Meitner Group Leader at Max Planck Institute for Biophysical Chemistry
3D DNA Organization and Gene Activity - Valentina Boeva, Ph.D. - Group Leader, Group Leader, Computational Genomics of Cancer, ETH Zürich, Switzerland
Fast and Accurate Prediction of Enhancer-Promoter Interactions Qcross Cell Types and Genetic Variants with Universal EPI
Date: April 4, 2025
Time: 7:00 a.m. (PDT) / 3:00 p.m. (BST)
Keynote Speaker: Ioannis Aifantis, Ph.D. – Professor and Chair – NYU Langone Medical Center, New York, USA
3D Chromosomal Hubs in Human Cancer
Date: March 7, 2025
Time: 3:00 p.m. (GMT) / 7:00 a.m. (PST)
Invited Speakers:
- Raffaella Santoro, Ph.D. – Professor and Group Leader, Dept. of Molecular Mechanisms of Disease, University of Zurich, Switzerland
Genome Organization and Function Around Nucleoli
Date: February 7, 2025
Time: 3:00 p.m. (GMT) / 7:00 a.m. (PST)
Invited Speakers:
- Michael Kharas, Ph.D. – Member in Molecular Pharmacology at Memorial Sloan Kettering Cancer Center, New York, USA
Regulators that Orchestrate RNA and Cellular Fates
Date: January 10, 2025
Time: 3:00 p.m. (GMT) / 7:00 a.m. (PST)
Invited Speakers:
- Jose Ignacio Martin-Subero, Ph.D. – Hospital Clinic Barcelona, (IDIBAPS), Spain
Beyond Gene Regulation: Biological and Clinical Impact of Epigenetic Memory in Lymphoid Tumors
Date: December 13, 2024
Time: 3:00 p.m. (GMT) / 7:00 a.m. (PST)
Invited Speakers:
- Scott Armstrong, M.D., Ph.D. – Dana Farber Cancer Inst., Boston Children's Hospital, Harvard Medical School and Broad Inst. of MIT & Harvard
Targeting the KMT2A:Menin Complex in Leukemia and Beyond
Date: October 11, 2024
Time: 3:00 p.m. (BST) / 7:00 a.m. (PDT)
Invited Speakers:
- Alex Radzisheuskaya, Ph.D. – Group Leader, Division of Cancer Biology at the Institute of Cancer Research, London
Investigating the Oncogenic Role of Histone Acetyltransferase Fusions in Acute Myeloid Leukaemia - Renee Beekman, Ph.D. – Group Leader, Centre for Genomic Regulation (CRG), Barcelona, Spain
Charting Early Lymphoma Formation from the Epigenomics Perspective
Date: August 23, 2024
Time: 3:00 p.m. (BST) / 7:00 a.m. (PDT)
Invited Speaker:
- Sean Bendall, Ph.D. – Associate Professor, Stanford University, USA
Bottom-Up Organization of Single Cell Human Systems
Date: August 2, 2024
Time: 3:00 p.m. (BST) / 7:00 a.m. (PDT)
Invited Speakers:
- Sandra Schick, Ph.D. - Group Leader at Institute of Molecular Biology (IMB), Mainz, Germany
BAF Chromatin Remodelers in Development and Disease - Konstantinos Tzelepsis, Ph.D. - Group Leader, Cambridge Stem Cell Inst. (CSCI), Cambridge, UK
The Therapeutic Potential of Epitranscriptomic Treatments in Disease
